Association of metabolic syndrome and oxidative stress with ischemic heart disease in middle-aged persons;Metabolinio sindromo ir oksidacinio streso sasaja su išemine širdies liga tarp vidutinio amžia us žmoniu

Medicina

Volumn 44, Issue 5, 2008, Pages 392-399

  Černiauskiene, Liucija Rita ^a   Lukšiene, Dalia Ieva ^a   Tamošiunas, Abdonas ^a   Reklaitiene, Regina ^a   Margevičiene, Lilija ^a  

^a KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

Author keywords

Ischemic heart disease; Metabolic syndrome; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; MALONALDEHYDE;

AGE; ARTICLE; BLOOD; COHORT ANALYSIS; COMPARATIVE STUDY; EVALUATION; FEMALE; FLUOROMETRY; HEART MUSCLE ISCHEMIA; HUMAN; LIPID PEROXIDATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OXIDATIVE STRESS; PREVALENCE; SEX DIFFERENCE;

AGE FACTORS; COHORT STUDIES; FEMALE; FLUOROMETRY; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OXIDATIVE STRESS; PREVALENCE; SEX FACTORS; VITAMIN E;

EID: 45749133588     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.3390/medicina44050051     Document Type: Article

References (35)

1. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106(25):3167-213.
2. European Guidelines on cardiovascular disease prevention in clinical practice. Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prevent Rehabil 2003; 10(Suppl 1):S1-78.
3. Lorenzo C, Williams K, Hunt KJ, Haffner SM. Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: The San Antonio Heart Study. Diabetes Care 2006;29(3):625-30.
4. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K, DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004;164(10):1066-76.
5. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110(10):1245-50.
6. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-28.
7. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005;28(2): 385-90.
8. Černiauskiene LR, Reklaitiene R, Lukšiene DI, Domarkiene S, Tamošiunas A, Margevičiene L. Metabolinio sindromo ryšys su išemine širdies liga tarp vidutinio amžiaus Kauno gyventoju. (Association of metabolic syndrome with ischemic heart disease among middle-aged Kaunas population.) Medicina (Kaunas) 2005;41(5):435-41.
9. černiauskiene LR, Domarkiene S, Lukšiene DI, Margevičiene L, Reklaitiene R, Tamošiunas A, et al. Metabolic syndrome and mortality from coronary heart disease in middle-aged men and women. Baltic Endocrinology 2005;1(1):5-10.
10. Lukšiene DI, černiauskiene LR. Metabolinis sindromas bei širdies ir kraujagysliu ligu rizika. (The metabolic syndrome and risks of cardiovascular disease.) Medicinos teorija ir praktika 2006;12(2):114-20.
11. Romero FJ, Bosch-Morell F, Romero MJ, Jareño EJ, Romero B, Marín N, et al. Lipid peroxidation products and antioxidants in human disease. Environ Health Perspect 1998;106 Suppl 5:1229-34.
12. Madamanchi N, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Tromb Vasc Biol 2005;31(1);29-38.
13. Serdar Z, Aslan K, Dirican M, Sarandol E, Yesilbursa D, Serdar A. Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary heart disease. Clin Biochem 2006;39(8):794-803.
14. Surekha RH, Srikanth BBMV, Jharna P, Ramachandra RV, Dayasagar RV, Jyothy A. Oxidative stress and total antioxidant status in myocardial infarction. Singapore Med J 2007,48(2): 137-42.
15. Bir LS, Demir S, Rota S, Koseoglu M. Increased serum malondialdehyde levels in chronic stage of ischemic stroke. Tohoku J Exp Med 2006;208:33-9.
16. Černiauskiene LR, Lukšiene DI, Lašiene J, Žalinkevičius R, Norkus A, Margevičiene L, et al. An influence of diabetes or hyperglycemia and increased level of lipid peroxidation on risk of stroke and myocardial infarction in elderly persons. Baltic Endocrinology 2006;2(2):63-7.
17. Adhikari D, Baxi J, Risal S, Singh PP. Oxidative stress and antioxidant status in cancer patients and healthy subjects, a case-control study. Nepal Med Coll J 2005;7:112-5.
18. Černiauskiene LR. Antioksidantiniai vitaminai E ir A: epidemiologiniai, klinikiniai ir eksperimentiniai tyrimai. (Antioxidant vitamins E and A: An epidemiological, clinical, and experimental study.) [dissertation]. Kaunas: Medicinos akademija; 1994.
19. Neunteufl T, Priglinger U, Heher S, Zehetgruber M, Soregi G, Lehr S, et al. Effects of vitamin E on chronic and acute endothelial dysfunction in smokers. JACC 2000;35:277-83.
20. Černiauskiene LR. Vitaminas E ir išeminės širdies ligos rizika: Epidemiologiniu ir klinikiniu studiju duomenys. (Vitamin E and risk of ischemic heart disease: Data of epidemiological and clinical studies.) Lith J Cardiol 2003;10:191-200.
21. Rajasekhar D, Strinivasa Rao PV, Latfeef SA, Saibaba KS, Subramanyam G. Association of serum antioxidants and risk of coronary heart disease in South Indian population. Indian J Med Sci 2004;58(11):465-71.
22. Sebekova K, Boor P, Valachovicova M, Blazicek P, Parrak V, Babinska K, et al. Association of metabolic syndrome risk factors with selected markers of oxidative status and microinflammation in healthy omnivores and vegetarians. Mol Nutr Food Res 2006;50(9):585-68.
23. Holvoet P, Kritchevsky SB, Tracy RP, Mertens A, Rubin SM, Butler J, et al. The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes 2004;53(4):1068-73.
24. Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations. Diabetes 2003;52: 2346-52.
25. World Health Organization MONICA Project. MONICA Manual: Monitoring of Trends and Determinants in Cardiovascular Disease. Geneva, Switzerland: Cardiovascular Disease Unit, WHO; 1990.
26. Prineas RJ, Crow RS, Blackburn H. The Minnesota code manual of electrocardiographic findings. London: John Wright; 1982.
27. Stein EA, Myers GL. National Cholesterol Education Program. Recommendations for triglycerides measurement: Executive summary. Clin Chem 1995;4:1421-6.
28. Warnick GR, Albers JJ. HDL cholesterol quantitation: Comparison of six precipitation methods and ultracentrifugation. In: Lippel K, editors. Report of the High Density Lipoprotein Methodology Workshop. NIH publication No. 79-1661. San Francisco, California: US Department of Health, Education, and Welfare; 1979. p. 53-69.
29. Varškevičiene ZM. Malondialdehido koncentracijos kraujo serume nustatymas, taikant kokybės kontrole. Metodinės rekomendacijos. (The measurement of concentration of malondialdehyde in blood serum using quality control. Methodical recommendations.) Kaunas: Z. Januškevičiaus širdies ir kraujagysliu sistemos fiziologijos ir patologijos mokslo tyrimo institutas; 1988.
30. Černiauskiene LR. Vitaminu E ir A koncentraciju kraujo serume vienalaikio fluorimetrinio nustatymo metodas, taikant laboratorine kokybės kontrole. Metodinės rekomendacijos. (The measurement of concentrations of vitamins E and A in blood serum by fluorimetrical method using quality control. Methodical recommendations.) Kaunas: Z. Januškevičiaus širdies ir kraujagysliu sistemos fiziologijos ir patologijos mokslo tyrimo institutas; 1987.
31. Bojarskiene F, Černiauskiene LR, Paunksnis A, Lukšiene DI. Metabolinio sindromo ir jo komponentu ryšys su katarakta. (Association of metabolic syndrome components with cataract.) Medicina (Kaunas) 2006;42(2):115-22.
32. Butnoriene J, Norkus A, Bunevičius R, Lašas L. Metabolinio sindromo diagnostikos kriteriju ivertinimas nustatant atsparuma insulinui. (Evaluation of diagnostic criteria for metabolic syndrome to identify insulin resistance.) Medicina (Kaunas) 2006;42(6):455-63.
33. Černiauskiene LR, Lukšiene DI, Margevičiene L, Tamošiunas A. An influence of smoking and metabolic syndrome on the level of lipid peroxidation of middle-aged men. Eur J Pub Health 2006;16(Suppl 1):147.
34. Ble-Castillo JL, Carmona-Diaz E, Mendez JD, Larios-Medina FJ, Medina-Santillan R, Cleva-Villanueva G, et al. Effect of alpha-tocopherol on the metabolic control and oxidative stress in female type 2 diabetics. Biomed Pharmacother 2005;59(6): 290-5.
35. Harris A, Devaraj S, Jialal I. Oxidative stress, alpha-tocopherol, and atherosclerosis. Current Atherosclerosis Reports 2002;4:373-80.